68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases

Nuklearmedizin. 2009;48(5):N52-4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anilides / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Cell Differentiation
  • Cisplatin / therapeutic use
  • Etoposide / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Nitriles / therapeutic use
  • Octreotide / analogs & derivatives*
  • Positron-Emission Tomography
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology*
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed / methods
  • Tosyl Compounds / therapeutic use

Substances

  • Anilides
  • Antineoplastic Agents
  • Nitriles
  • Radiopharmaceuticals
  • Tosyl Compounds
  • Etoposide
  • bicalutamide
  • Prostate-Specific Antigen
  • Cisplatin
  • Octreotide
  • Edotreotide